Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
Arch Therapeutics, Inc. (ARTH) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
10/04/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Form of Amendment No. 11 to the First Notes",
"Form of Amendment No. 11 to the Second Notes",
"Form of Amendment No. 6 to the Third Notes"
09/27/2023 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: " "
08/23/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Arch Therapeutics, Inc. Amended and Restated 2023 Equity Incentive Plan"
08/22/2023 PRE 14C Form PRE 14C - Other preliminary information statements:
08/11/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 SC 13G Stahl Andrew reports a 9.9% stake in Arch Therapeutics, Inc.
08/04/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Form of Amendment No. 9 to the First Notes",
"Form of Amendment No. 9 to the Second Notes",
"Form of Amendment No. 4 to the Third Notes"
07/25/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/24/2023 8-K Quarterly results
07/14/2023 SC 13G BIGGER CAPITAL FUND L P reports a 9.9% stake in Arch Therapeutics, Inc.
07/13/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events  Interactiv...
07/12/2023 SC 13G Oasis Capital, LLC reports a 10% stake in Arch Therapeutics, Inc.
07/07/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Form of Amendment No. 7 to the First Notes",
"Form of Amendment No. 7 to the Second Notes",
"Form of Amendment No. 2 to the Third Notes"
04/20/2023 8-K Quarterly results
03/16/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "Form of Exchange Agreement",
"Form of Amendment No. 2 to the First Notes",
"Form of Amendment No. 2 to the Second Notes",
"Form of Amendment No. 3 to the First Notes",
"Form of Amendment No. 3 to the Second Notes",
"Form of Amendment No. 1 to Series 1 Notes",
"Form of Amendment No. 1 to Series 2 Notes"
03/09/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Press Release issued by Arch Therapeutics, Inc."
03/07/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: " "
01/30/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
01/27/2023 SC 13G/A Parker Michael Andrew reports a 8.5% stake in Arch Therapeutics, Inc.
01/25/2023 SC 13G/A Parker Michael Andrew reports a 8.5% stake in Arch Therapeutics, Inc.
01/23/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
01/17/2023 8-K Quarterly results
12/28/2022 10-K Annual Report for the period ended September 30, 2022
12/02/2022 8-K Quarterly results
10/25/2022 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
09/30/2022 8-K Quarterly results
08/31/2022 EFFECT Form EFFECT - Notice of Effectiveness:
08/30/2022 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
08/19/2022 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
08/17/2022 PRE 14A Form PRE 14A - Other preliminary proxy statements:
08/17/2022 8-K/A Quarterly results
08/16/2022 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: " "
08/15/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy